"We are a member site of ENCORE Research Group, a premier clinical research organization that has conducted more than 2,500 clinical trials over 20 years and has worldwide recognition for providing patients access to cutting edge medical research. If you have a medical issue and want a research solution, or if you are a healthy volunteer, come visit our center and learn more. One of our experts will be happy to evaluate you."

During the past decade, Westside Center for Clinical Research conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 24 clinical trials were completed, i.e. on average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 11 clinical trials were completed. i.e. 122.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Westside Center for Clinical Research" #1 sponsor was "Pfizer" with 10 trials, followed by "AstraZeneca" with 3 trials sponsored, "Iroko Pharmaceuticals, LLC" with 3 trials sponsored, "Allergan" with 2 trials sponsored and "Enanta Pharmaceuticals, Inc" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Westside Center for Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "TIMI Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Westside Center for Clinical Research" are "Osteoarthritis" (8 trials), "Arthritis" (4 trials), "Cardiovascular Disease" (3 trials), "Type 2 Diabetes" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Westside Center for Clinical Research" in a lesser frequency.

Most popular intervention types in "Westside Center for Clinical Research" are "Drug" (23 trials), "Biological" (9 trials), "Other" (6 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Dapagliflozin" (3 trials), "tanezumab" (3 trials), "Atogepant" (2 trials) and "Diclofenac" (2 trials). Other intervention names were less common.

The vast majority of trials in "Westside Center for Clinical Research" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Westside Center for Clinical Research". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Westside Center for Clinical Research, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Westside Center for Clinical Research, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".